[227]
Whether or not a patentee has obtained enough data to substantiate an invention is an irrelevant consideration with respect to the issue of sufficiency of disclosure. (
Pfizer v. Ranbaxy
, above at para. 56;
Pfizer v. Pharmascience
, above at para. 67.)
Obviousness